These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 1694928

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antihypertensive therapy in diabetic patients.
    Weidmann P, Boehlen LM, de Courten M, Ferrari P.
    J Hum Hypertens; 1992 Dec; 6 Suppl 2():S23-36. PubMed ID: 1289510
    [Abstract] [Full Text] [Related]

  • 5. Hypertension and insulin resistance.
    Prichard BN, Smith CC, Sen S, Betteridge DJ.
    J Cardiovasc Pharmacol; 1992 Dec; 20 Suppl 11():S77-84. PubMed ID: 1284147
    [Abstract] [Full Text] [Related]

  • 6. [Insulin resistance and cardiovascular complications].
    Janka HU.
    Wien Klin Wochenschr; 1994 Dec; 106(24):758-62. PubMed ID: 7846894
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.
    Khan NA, McAlister FA, Lewanczuk RZ, Touyz RM, Padwal R, Rabkin SW, Leiter LA, Lebel M, Herbert C, Schiffrin EL, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, DeChamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Campbell NR, Arnold M, Moe G, Hill MD, Jones C, Larochelle P, Ogilvie RI, Tobe S, Houlden R, Burgess E, Feldman RD, Canadian Hypertension Education Program.
    Can J Cardiol; 2005 Jun; 21(8):657-72. PubMed ID: 16003449
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Cardiovascular risk factors and prevention in women: similarities and differences].
    Sclavo M.
    Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880
    [Abstract] [Full Text] [Related]

  • 11. Classical risk factors and emerging elements in the risk profile for coronary artery disease.
    Gensini GF, Comeglio M, Colella A.
    Eur Heart J; 1998 Feb; 19 Suppl A():A53-61. PubMed ID: 9519344
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diabetes mellitus and hypertension.
    Hamilton BP.
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):20-9. PubMed ID: 2220797
    [Abstract] [Full Text] [Related]

  • 14. Insulin resistance and essential hypertension: pathophysiologic and therapeutic implications.
    Santucci A, Ferri C.
    J Hypertens Suppl; 1992 Apr; 10(2):S9-15. PubMed ID: 1593308
    [Abstract] [Full Text] [Related]

  • 15. Insulin resistance as an intermediary endpoint.
    Lithell HO.
    Blood Press Suppl; 1997 Apr; 2():108-12. PubMed ID: 9495638
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy.
    Khan NA, McAlister FA, Campbell NR, Feldman RD, Rabkin S, Mahon J, Lewanczuk R, Zarnke KB, Hemmelgarn B, Lebel M, Levine M, Herbert C, Canadian Hypertension Education Program.
    Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142
    [Abstract] [Full Text] [Related]

  • 18. Treatment of hypertension in chronic kidney disease.
    Toto RD.
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.